NEW YORK (GenomeWeb News) - Rosetta Genomics said today that it has licensed Nanogen’s MGB Probe technology for use with a line of microRNA biomarker-based diagnostic tests that it plans to launch in 2008.
 
Rosetta plans to use the MGB, or minor groove binder, probes to develop a line of real-time PCR-based diagnostic tests.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.